Abdul Ezaz Mutlib
Chief Executive Officer at FRONTAGE HOLDINGS CORPORATION
Net worth: 75 638 $ as of 2024-03-30
Profile
Abdul Ezaz Mutlib is currently the Chief Executive Officer at Frontage Laboratories, Inc. since 2010.
He is also the Chief Executive Officer at Frontage Holdings Corp.
since 2017.
Additionally, Dr. Mutlib has been a Member of the American Society For Mass Spectrometry since 1990.
In the past, he worked as the Director-Drug Metabolism at Pfizer Inc. from 2006 to 2010.
He also held positions as a Principal at Wyeth LLC, DuPont Merck Pharmaceutical Co., and Hoechst-Roussel Pharmaceuticals, Inc. Dr. Mutlib completed his undergraduate degree at The University of Sydney in 1987.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FRONTAGE HOLDINGS CORP.
0.02% | 2024-01-25 | 411,098 ( 0.02% ) | 75 638 $ | 2024-03-30 |
Abdul Ezaz Mutlib active positions
Companies | Position | Start |
---|---|---|
FRONTAGE HOLDINGS CORPORATION | Chief Executive Officer | 2023-01-02 |
Frontage Laboratories, Inc.
Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Chief Executive Officer | 2009-12-31 |
American Society For Mass Spectrometry | Corporate Officer/Principal | 1989-12-31 |
Former positions of Abdul Ezaz Mutlib
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 2010-01-31 |
Hoechst-Roussel Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Training of Abdul Ezaz Mutlib
The University of Sydney | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
FRONTAGE HOLDINGS CORPORATION | Health Technology |
Private companies | 5 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Frontage Laboratories, Inc.
Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Commercial Services |
Hoechst-Roussel Pharmaceuticals, Inc. | |
American Society For Mass Spectrometry |
- Stock Market
- Insiders
- Abdul Ezaz Mutlib